Limitation of no reflow injury by blood-free reperfusion with oxygenated perfluorochemical (fluosol-DA 20%)

Journal of the American College of Cardiology

Volumn 18, Issue 1, 1991, Pages 215-223

  Kolodgie, Frank D ^a   Virmani, Renu ^a   Farb, Andrew ^a  

^a NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOSOL DA;

ANIMAL EXPERIMENT; ARTICLE; CORONARY ARTERY OBSTRUCTION; DOG; INTRAVENOUS DRUG ADMINISTRATION; NONHUMAN; PRIORITY JOURNAL; REPERFUSION INJURY;

EID: 0025766033     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(10)80242-6     Document Type: Article

References (25)

1. Studies of experimental coronary artery reperfusion: effects on infarct size, myocardial function, biochemistry, ultrastructure and microvascular damage
2. The wavefront phenomenon of ischemic cell death. I. Myocardial infarct size vs. duration of coronary occlusion in dogs
3. Preservation of global and regional left ventricular function after early thrombolysis in acute myocardial infarction
4. A prospective trial of intravenous streptokinase in acute myocardial infarction (I.S.A.M.): mortality, morbidity, and infarct size at 21 days
5. The “no-refiow” phenomena after temporary occlusion in the dog
6. Ultrastructural evidence of microvascular damage and myocardial cell injury after coronary occlusion: which comes first?
7. Effect of perfluorochemical Fluosol-DA on infarct morphology in dogs with permanent coronary artery occlusion
8. Reduction of infarct size with intracoronary perfluorochemical in a canine preparation of reperfusion
9. Preservation of endothelial cell structure and function by intracoronary perfluorochemical in a canine preparation of reperfusion
10. Limitation of myocardial reperfusion injury by intravenous perfluorochemicals: role of neutrophil activation
11. Beneficial long-term effect of intracoronary perfluorochemical on infarct size and ventricular function in a canine reperfusion model
12. Evaluation of nonradioactive colored microspheres for measurement of regional myocardial blood flow in dogs
13. Reduction of reperfusion injury in the canine preparation by intracoronary adenosine: importance of the endothelium and the no-reflow phenomenon
14. Randomized trial of intravenous streptokinase, oral aspirin, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2
15. Emergency percutaneous transluminal coronary angioplasty in acute myocardial infarction: a 3-year experience
16. The role of surgical reperfusion in myocardial infarction
17. Role of leukocytes in the response to acute myocardial ischemia and reflow in dogs
18. Accumulation of polymorphonuclear leukocytes during 3 hours of experimental ischemia
19. Myocardial reperfusion: a double-edged sword?
20. Endothelial and myocardial injury during ischemia and reperfusion: pathogenesis and therapeutic implications
21. Effect of a transient period of ischemia on myocardial cells. II. Fine structure during the first few minutes of reflow
22. Progressive impairment of regional myocardial perfusion after initial restoration of postishemic blood flow
23. The effect of perfluorochemical Fluosol-DA (20%) on myocardial infarct healing in the rabbit
24. Effects of intravenous fluorocarbons during and without oxygen enhancement on acute myocardial ischemic injury assesses by measurement of intramyocardial gas tensions
25. reduction in size of experimental myocardial infarction